By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3.5% on Monday after ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Novo Nordisk A/S’s next-generation obesity shot CagriSema helped patients lose weight in large studies despite only about ...

Danish drugmaker Novo Nordisk A/S said on Monday it is terminating a recently formed obesity-drug partnership with Hims & ...

Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...

Nearly 1 in 4 people have sarcopenic obesity, a dangerous condition mixing muscle loss and weight gain. Learn the warning signs and prevention tips.

For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

Obesity caused by a high-fat Western diet damages the pancreas, affecting insulin production and blood sugar control even ...